Save your place

Sign in to WhoBought

Please try again later.

Fate Therapeutics, Inc. (FATE) institutional ownership

Latest close $2.41 Jul 24, 2026
Market cap$123M 52-week range SectorHealthcare
Funds holding · Q1 2026
124
reported FATE position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
78 buyers · 46 sellers

Fate Therapeutics, Inc. (FATE) price and institutional activity

Dates

Q1 2026

$0 bought by 78 investors
AQR Capital Management LLCTwo Sigma Investments, LP +76 more
$0 sold by 46 investors
Vestal Point Capital, LPTwo Sigma Advisers, LP +44 more
Bought Sold Totals per quarter; hover a bar for the names.

Fate Therapeutics, Inc. (FATE) institutional activity · 124

Investor Type Est. change Change Δ Own Date
AQR Capital Management LLC · Added
Change +1.8M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +1.8M Q1 2026
Two Sigma Investments, LP · Added
Change +1.7M Δ Own +99.9% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.7M +99.9% Q1 2026
Vestal Point Capital, LP · Exited
Change −1.7M Δ Own −100.0% Date Q1 2026
Vestal Point Capital, LP Exited· Q1 2026 −1.7M −100.0% Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.7M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.7M −100.0% Q1 2026
Point72 Asset Management, L.P. · Reduced
Change −1.5M Δ Own −97.2% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −1.5M −97.2% Q1 2026
UBS Group AG · Added
Change +1.4M Date Q1 2026
UBS Group AG Added· Q1 2026 +1.4M Q1 2026
Acadian Asset Management LLC · Added
Change +1.2M Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +1.2M Q1 2026
Irenic Capital Management LP · New
Change +878K Date Q1 2026
Irenic Capital Management LP New· Q1 2026 +878K Q1 2026
Dimensional · Reduced
Change −694K Date Q1 2026
Dimensional Reduced· Q1 2026 −694K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +614K +26.0% Q1 2026
Millennium Management LLC · Exited
Change −523K Δ Own −100.0% Date Q1 2026
Millennium Management LLC Exited· Q1 2026 −523K −100.0% Q1 2026
Knott David M Jr · Exited
Change −365K Δ Own −100.0% Date Q1 2026
Knott David M Jr Exited· Q1 2026 −365K −100.0% Q1 2026
Connor, Clark & Lunn Investment Management Ltd. · Added
Change +359K Date Q1 2026
Connor, Clark & Lunn Investment Management Ltd. Added· Q1 2026 +359K Q1 2026
Barclays PLC · Reduced
Change −236K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −236K Q1 2026
Ieq Capital, LLC · Added
Change +203K Date Q1 2026
Ieq Capital, LLC Added· Q1 2026 +203K Q1 2026
Data through Q1 2026 · filed Jun 1, 2026
15 of 124

Famous investor activity in Fate Therapeutics, Inc. (FATE)

Fate Therapeutics, Inc. (FATE) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Redmile Group, LLC · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Redmile Group, LLC Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Lee Michael Stewart · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Lee Michael Stewart Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Xu Yuan · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Xu Yuan Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Jooss Karin · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Jooss Karin Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Epstein Robert S. · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Epstein Robert S. Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Agarwal Shefali · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Agarwal Shefali Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Abernethy Matt · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Abernethy Matt Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Rastetter William H. · Director Grant (A) 88K
Owned 88K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Rastetter William H. Director Grant (A) 88K 88K Jun 12, 2026 Jun 15, 2026
Hamill Laura · Director Grant (A) 176K
Owned 176K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Hamill Laura Director Grant (A) 176K 176K Jun 12, 2026 Jun 15, 2026
Tahl Cindy · Officer Sell −$48K
Price $1.88 Qty −26K Owned 628K Trade date May 20, 2026 Filed date May 21, 2026
Tahl Cindy Officer Sell $1.88 −26K −$48K 628K May 20, 2026 May 21, 2026
Valamehr Bahram · Director Sell −$54K
Price $1.88 Qty −29K Owned 636K Trade date May 20, 2026 Filed date May 21, 2026
Valamehr Bahram Director Sell $1.88 −29K −$54K 636K May 20, 2026 May 21, 2026
Tahl Cindy · Officer 4 operations 0
Price $1.05–$1.32 Owned 356K Trade date May 6, 2026 Filed date May 7, 2026
Tahl Cindy Officer 4 operations $1.05–$1.32 0 356K May 6, 2026 May 7, 2026
Epstein Robert S. · Director 2 operations 50K
Price $1.69 Owned 0 Trade date May 5, 2026 Filed date May 6, 2026
Epstein Robert S. Director 2 operations $1.69 50K 0 May 5, 2026 May 6, 2026
Rastetter William H. · Director 2 operations 50K
Price $1.69 Owned 0 Trade date May 5, 2026 Filed date May 6, 2026
Rastetter William H. Director 2 operations $1.69 50K 0 May 5, 2026 May 6, 2026
Redmile Group, LLC · Director 8 operations 0
Owned 2.8M Trade date Apr 20, 2026 Filed date Apr 22, 2026
Redmile Group, LLC Director 8 operations 0 2.8M Apr 20, 2026 Apr 22, 2026
15 of 23
15 of 23 Sign in to continue to older insider transactions.

Fate Therapeutics, Inc. (FATE) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Redmile Group, LLC 17.6M
% of shares outstanding 14.9% Filing date Mar 25, 2024
Redmile Group, LLC 17.6M 14.9% Mar 25, 2024
BlackRock Inc. 11.2M
% of shares outstanding 11.4% Filing date Jan 24, 2024
BlackRock Inc. 11.2M 11.4% Jan 24, 2024
Ark Investment Management LLC 10.3M
% of shares outstanding 10.8% Filing date Feb 9, 2022
Ark Investment Management LLC 10.3M 10.8% Feb 9, 2022
Boxer Capital, LLC 6.2M
% of shares outstanding 6.3% Filing date Feb 12, 2024
Boxer Capital, LLC 6.2M 6.3% Feb 12, 2024
Point72 Asset Management, L.P. 4.7M
% of shares outstanding 4.8% Filing date Jan 25, 2024
Point72 Asset Management, L.P. 4.7M 4.8% Jan 25, 2024
FMR LLC 2.2M
% of shares outstanding 2.4% Filing date Oct 12, 2021
FMR LLC 2.2M 2.4% Oct 12, 2021
Blackrock, Inc. 2.2M
% of shares outstanding 1.9% Filing date Jul 8, 2026
Blackrock, Inc. 2.2M 1.9% Jul 8, 2026
State Street Corp
% of shares outstanding 1.9% Filing date Jan 22, 2024
State Street Corp 1.9% Jan 22, 2024
8 of 12

Fate Therapeutics, Inc. (FATE) ownership FAQ

Who owns FATE?

124 reporting institutions disclosed FATE position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.